1	Ultrastructural Probes of Active DNA Sites, and the RNA Activators of DNA. John H. Frenster Division of Medical Oncology, Stanford University, and The Euchromatin Network
2	The Discovery of the Mitogenic Activity of PHA.
3	Normal Human Peripheral Blood Lymphocytes.
4	³H-PHA Cultures of Normal Human Peripheral Blood.
5	Ultrastructural DNase I-Sensitive Probes within a Human Acute Leukemia Myelocyte.
6	Specificity of DNase I and Acridine Orange for Reaction.
7	Probe Counts of Active DNA within Mitotic Cells.
8	Probe Counts within Dividing Human Bone Marrow Cells.
9	Probe Counts of Active DNA within Normal Human Marrow Differentiating Granulocytes.
10	Probe counts within normal human differentiating marrow cells.
11	Probe Counts of Active DNA within Normal Human Marrow Differentiating Erythrocytes.
12	Probe counts within normal human differentiating marrow cells.
13	Probe Counts of Active DNA within Normal Human Marrow Differentiating Monocytes.
14	Probe Counts of Active DNA within Normal Human Marrow Undifferentiated Cells.
15	Probe counts within human normal marrow mononuclear cells.
16	Probe Counts of Active DNA within Normal Human Bone Marrow Differentiated Cells.
17	Probe Counts of Active DNA within Hodgkin Lymphoma Lymph Node Lymphocytes.
18	Probe Counts within Lymphocytes in Hodgkin Lymphoma.
19	Probe Counts of Active DNA within Neoplastic Cells in Hodgkin Lymphoma Lymph Nodes.
20	In Vivo Activity of Lymph Node Cells in Hodgkin Lymphoma
21	Probe Counts of Active DNA within Neoplastic Cells in Hodgkin Lymphoma Lymph Nodes.
22	In Vivo Activity of Neoplastic Cells in Hodgkin Lymphoma.
23	Interaction of Neoplastic Cells with Surrounding Lymphocytes in Hodgkin Lymphoma Lymph Nodes.
24	Interaction of Neoplastic Cells with Surrounding Lymphocytes in Hodgkin Lymphoma Lymph Nodes.
25	In Vivo Effect of Apposition on Lymphocytes in Hodgkin Lymphoma.
26	In Vivo Activity of Apposed Lymphocytes in Hodgkin Lymphoma.
27	Cellular Immuno-Phenotypes in Hodgkin Lymphoma.
28	Candidate Chemokine Molecular Species for Intercellular Signaling in Hodgkin Lymphoma.
29	Candidate Genome Sequences for Intercellular Signaling in Hodgkin Lymphoma.
30	Isolated Nuclei from Calf Thymus Lymphocytes.
31	Ultrastructure of Euchromatin in Calf Thymus Lymphocytes.
32	Analysis of Isolated Euchromatin and Heterochromatin.
33	Thermal Hyperchromicity of DNA while within Repressed Heterochromatin and Active Euchromatin.
34	RNA Synthesis within Isolated Euchromatin and Heterochromatin.
35	Sensitivity of RNA Synthesis within Isolated Active Euchromatin and Repressed Heterochromatin.
36	Activation of Isolated Repressed Heterochromatin.
37	De-repression and Re-programming of Isolated Chromatin.
38	Comparison of RNA Species as Activators of Transcription.
39	Chromatin Re-modeling by Nuclear Polyanions.
40	Conclusions: 1. DNase I-sensitive probes allow identification of active DNA sites within intact cells. 2. Such sites vary characteristically during cell activation, cell division, and cell differentiation. 3. During lymphocyte activation within Hodgkin lymphoma lymph nodes, active DNA sites undergo unipolar clustering toward neoplastic cells. 4. Such unipolar clustering may reflect signals from the neoplastic cells to the surrounding lymphocytes. 5. DNase I-sensitive probes permit the analysis of euchromatin activation by RNA within human intact cells. ( www.euchromatin.net ).
41	The Continuing Challenge: Human Acute Myelocytic Leukemia.
42	Frenster Euchromatin Lab Cell Culture: Cell Morphometry: Lorraine Meisner Michael Papalian Albert Keshgegian Jeff Frenster Sharon Landrum Stanford Medical Students: Elsie Siegel David Stanley Electron Microscopy: Brent Archibald Marilyn Masek Paul Herstein Shirley Nakatsu Leonard Wilson Marie Shatos Bruce Allen Cheryl Hayden Daniel Rhoades Reed Rowan Secretarial: John Thompson Janice Smith